IPO registrations (S-1, F-1) · Registrants
Capstone Holding Corp.
- SEC CIK
- 887151 · filings on EDGAR ↗
- Former names
- Capstone Therapeutics Corp. (2010–2019); ORTHOLOGIC CORP (1995–2010); ORTHOLOGIC CORPORATION (1994–1994)
- Registration
- Form S-1, first filed 2015-06-26, last 2026-10-30; 8 initial registrations, 5 amendments
- Outcome
- Final prospectus filed 2025-03-07; declared effective 2025-02-14
- Industry (SIC)
- Wholesale-Lumber & Other Construction Materials 5030
- Incorporated in
- NV
- Business address
- 18400 76TH AVENUE, Tinley Park, IL 60477
- EIN
- 86-0585310
- Ticker
- CAPS (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Capstone Holding Corp. on the corporate pages
Offering terms
- Final price
- $4.00 per share (424B4 filed 2025-03-07)
- Shares sold
- 1,250,000
- Gross proceeds
- $5,000,000 before underwriting discounts and any over-allotment option
- Listing
- OTCQB under the symbol CAPS
- Lead underwriters
- Joseph Gunnar
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form 5500 plan sponsor: CAPSTONE THERAPEUTICS CORP. EXACT (EIN (EXACT))
- Form D issuer: Capstone Therapeutics Corp. EXACT (CIK (EXACT))
- SEC filer: Capstone Holding Corp. EXACT (CIK (EXACT))
Filings 20
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2015-06-26 | S-1 | S-1 (registration) | Capstone Therapeutics Corp. | 0001171843-15-003613 ↗ |
| 2015-07-02 | S-1/A | S-1/A (amendment) | Capstone Therapeutics Corp. | 0001171843-15-003668 ↗ |
| 2015-09-16 | S-1/A | S-1/A (amendment) | Capstone Therapeutics Corp. | 0001171843-15-005177 ↗ |
| 2024-12-31 | S-1 | S-1 (registration) | Capstone Holding Corp. | 0001213900-24-114111 ↗ |
| 2025-01-27 | S-1/A | S-1/A (amendment) | Capstone Holding Corp. | 0001213900-25-006659 ↗ |
| 2025-02-06 | S-1/A | S-1/A (amendment) | Capstone Holding Corp. | 0001213900-25-010833 ↗ |
| 2025-02-14 | EFFECT | EFFECT (declared effective) | Capstone Holding Corp. | 9999999995-25-000464 ↗ |
| 2025-03-07 | 424B4 | 424B4 (final prospectus) | Capstone Holding Corp. | 0001213900-25-021464 ↗ |
| 2025-06-03 | S-1 | S-1 (registration) | Capstone Holding Corp. | 0001213900-25-050786 ↗ |
| 2025-06-09 | S-1/A | S-1/A (amendment) | Capstone Holding Corp. | 0001213900-25-052677 ↗ |
| 2025-06-11 | EFFECT | EFFECT (declared effective) | Capstone Holding Corp. | 9999999995-25-001893 ↗ |
| 2025-06-12 | 424B4 | 424B4 (final prospectus) | Capstone Holding Corp. | 0001213900-25-053782 ↗ |
| 2025-08-04 | S-1 | S-1 (registration) | Capstone Holding Corp. | 0001213900-25-071454 ↗ |
| 2025-08-11 | EFFECT | EFFECT (declared effective) | Capstone Holding Corp. | 9999999995-25-002563 ↗ |
| 2025-10-23 | S-1 | S-1 (registration) | Capstone Holding Corp. | 0001213900-25-101720 ↗ |
| 2026-06-29 | S-1 | S-1 (registration) | Capstone Holding Corp. | 0001437749-26-021891 ↗ |
| 2026-06-29 | S-1 | S-1 (registration) | Capstone Holding Corp. | 0001437749-26-021892 ↗ |
| 2026-07-09 | EFFECT | EFFECT (declared effective) | Capstone Holding Corp. | 9999999995-26-002241 ↗ |
| 2026-07-09 | EFFECT | EFFECT (declared effective) | Capstone Holding Corp. | 9999999995-26-002242 ↗ |
| 2026-10-30 | S-1 | S-1 (registration) | Capstone Holding Corp. | 0001437749-26-034247 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-06 | S-1/A | registration statement | $4.00 | 1,250,000 | $5,000,000 | OTCQB CAPS | 1 | primary document; price sentence, shares headline, proceeds computed, cover names 1 | document ↗ | |
| 2025-03-07 | 424B4 | final prospectus | $4.00 | 1,250,000 | $5,000,000 | OTCQB CAPS | 1 | primary document; price sentence, shares headline, proceeds table, cover names 1 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| CASEY MICHAEL D | Director | 3 | 2006–2007 | ||
| FELDMAN FREDRIC J | Director | 27 | 2006–2026 | ||
| HOLLIMAN JOHN M III | Director; Director,Officer | Executive Chairman | 37 | 2006–2026 | |
| HOWSE ELWOOD D | Director | 25 | 2006–2026 | ||
| WHITE AUGUSTUS A | Director | 22 | 2006–2012 | ||
| TAEGER LESLIE M | Officer | Chief Financial Officer; Chief Financiel Officer; Senior VP & CFO; SVP Chief Financial Officer | 18 | 2006–2017 | |
| RYABY JAMES T PHD | Officer | Chief Technology Officer; Sr VP Chief Scientific Officer; Sr.VP, CSO | 3 | 2006 | |
| Pusey James M | Director,Officer | Chief Executive Officer | 2 | 2006 | |
| Shinbaum Dana B | Officer | Sr VP Business Dev.; Vice Pres Business Development; VP, Bus.& Dev.; VP Business Development | 8 | 2006–2011 | |
| WARDELL WILLIAM M | Director | 18 | 2006–2012 | ||
| STEER RANDOLPH C | Officer; Other | President | 17 | 2006–2015 | |
| BIOTECHNOLOGY VALUE FUND II LP | Other; TenPercentOwnerOther | 9 | 2008–2017 | ||
| BIOTECHNOLOGY VALUE FUND L P | Other; TenPercentOwnerOther | 12 | 2008–2017 | ||
| BVF INC/IL | Other; TenPercentOwner; TenPercentOwnerOther | 13 | 2008–2017 | ||
| BVF INVESTMENTS LLC | Other; TenPercentOwnerOther | 13 | 2008–2017 | ||
| BVF PARTNERS L P/IL | Other; TenPercentOwner; TenPercentOwnerOther | 13 | 2008–2017 | ||
| Spiegel Robert J. | Director | 4 | 2010–2012 | ||
| LAMPERT MARK N | Other; TenPercentOwner | 11 | 2011–2017 | ||
| MILLER LLOYD I III | TenPercentOwner | 17 | 2012–2017 | ||
| Fangmann Eric W | Director | 6 | 2014–2016 | ||
| BP Peptides, LLC | Director,TenPercentOwner; TenPercentOwner | 2 | 2017–2018 | ||
| Lipman Matthew E. | Director,Officer,TenPercentOwner; Director,TenPercentOwner | Chief Executive Officer | 7 | 2017–2026 | |
| TOPOREK MICHAEL | Director; DirectorOther | 6 | 2017–2026 | ||
| SUBIN NEIL S | TenPercentOwner | 2 | 2018 | ||
| Alimco Financial Corp | Other | 1 | 2019 | ||
| SCHULTZ EDWARD CHRISTOPHER | Officer | Chief Financial Officer | 4 | 2025–2026 | |
| Grotke Kevin Allan | Officer | President & CEO of TotalStone | 2 | 2026 | |
| Strout Gordon Lewis Jr | Director | 2 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2017-07-17 | Capstone Therapeutics Corp. | Other | $3,440,000 | $0 | 0 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Form D issuer | Capstone Therapeutics Corp. | AZ | Form D private offerings | CIK (EXACT) |
| SEC filer | Capstone Holding Corp. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Capstone Holding Corp. | IL | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | CAPSTONE THERAPEUTICS CORP. | EIN (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.